3654 results for «460»

Filter By

3654 results

Stent it or leave it : SCAD dilemmas

20 May 2026 – From EuroPCR 2026

This session explores the complex dilemmas in managing spontaneous coronary artery dissection (SCAD), focusing on decision-making between conservative treatment and intervention. It presents diverse clinical cases highlighting varying presentations including STEMI, young patients, and drug-induced complications, offering critical perspectives on tailored treatment strategies.

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

20 May 2026 – From EuroPCR 2026

This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

Multi-device approach to calcified lesions

20 May 2026 – From EuroPCR 2026

Explore a multi-device strategy for tackling complex calcified coronary lesions in this session. It includes case studies on left main trifurcation stenting, resistant calcified nodules treated with orbital atherectomy, severe restenosis, and critical calcifications in challenging anatomies, showcasing advanced techniques for plaque modification and lesion management.

TAVI: head-to-head trials

20 May 2026 – From EuroPCR 2026

This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...

TAVI: head-to-head trials

TAVI for aortic regurgitation

20 May 2026 – From EuroPCR 2026

This session highlights innovative transcatheter aortic valve implantation (TAVI) approaches for treating aortic regurgitation, focusing on off-label uses and complex cases. It features high-risk patient interventions, including nonagenarian patients, and strategies to manage severe non-calcific native valve regurgitation with balloon-expandable valves.

Lost, crushed, fractured: stent complications in real life

20 May 2026 – From EuroPCR 2026

This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.

Lost, crushed, fractured: stent complications in real life

Transcatheter rescue in cardiogenic shock

20 May 2026 – From EuroPCR 2026

This session presents cutting-edge transcatheter rescue interventions in cardiogenic shock scenarios. It covers emergent valve-in-valve procedures, hybrid approaches for valvular heart disease with heart failure, management of ventricular septal rupture post-myocardial infarction, and percutaneous closure techniques for high-risk patients, emphasizing lifesaving interventional strategies.

Imaging guidance in everyday practice

20 May 2026 – From EuroPCR 2026

This session emphasizes the role of imaging guidance in everyday interventional cardiology practice. Through challenging cases involving exertional chest pain, unusual coronary anatomy, complex left ventricular access, side branch navigation, and IVUS-guided re-intervention, it underscores the critical value of advanced imaging for diagnostic clarity and procedural...

Imaging guidance in everyday practice

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the comprehensive management of ischemic heart disease in patients undergoing transcatheter aortic valve implantation (TAVI). It highlights the critical importance of maintaining coronary access post-TAVI and explores how various valve designs affect coronary accessibility, particularly in cases involving valve-in-valve (TAV-in-TAV) procedures, guiding...

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

Transcatheter options for degenerated surgical aortic valves - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Transcatheter options for degenerated surgical aortic valves - LIVE case

TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest without ST-segment elevation

29 Aug 2021

Elad Asher analyses this study which compared the benefits of immediate coronary angiography with those of initial intensive care assessment with delayed angiography after out-of-hospital cardiac arrest. Hot Line session of the ESC Congress 2021.

Elad Asher

Author

Elad Asher
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest without ST-segment elevation

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE coronary intravascular lithotripsy catheter meets primary safety and effectiveness endpoints

18 May 2026

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?